Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
25%
Ph phase_1
2
17%
Ph phase_3
1
8%
Ph phase_4
2
17%
Ph early_phase_1
1
8%
Ph phase_2
2
17%

Phase Distribution

3

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(6)

Detailed Status

unknown6
Completed3
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 12 (18.2%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A3 (27.3%)

Trials by Status

withdrawn18%
unknown650%
recruiting217%
completed325%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12